Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator.
Eur Heart J
; 8(8): 906-9, 1987 Aug.
Article
em En
| MEDLINE
| ID: mdl-3117553
ABSTRACT
Recombinant tissue-type plasminogen activator (rt-PA) was administered intravenously to a 64-years old female with thrombotic malfunction of a Björk-Shiley prosthetic tricuspid valve. 150 mg of single-chain rt-PA was infused over 8 hours followed by an additional dose of 50 mg over the next 8 hours. At the end of the first infusion, restoration of normal valve function was demonstrated by fluoroscopic and echo-Doppler examinations. Mild systemic activation of the fibrinolytic system occurred, with a decrease of fibrinogen and alpha 2-antiplasmin to 53% and 33%, respectively, of the preinfusion value at the nadir.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Trombose
/
Próteses Valvulares Cardíacas
/
Ativador de Plasminogênio Tecidual
Idioma:
En
Ano de publicação:
1987
Tipo de documento:
Article